Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2019

Quarterly Financial Data [Abstract]

Quarterly Financial Data

Quarterly Financial Data (Unaudited)

The table below summarizes the Company’s unaudited quarterly operating results for the last two fiscal years (in thousands, except per share amounts):

2019	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Year Ended
Revenue	$	147,953	$	168,182	$	146,815	$	163,445	$	626,395
Gross profit	$	48,952	$	68,584	$	45,296	$	54,849	$	217,681
Operating income	$	19,706	$	40,548	$	17,064	$	25,698	$	103,016
Net income	$	19,642	$	29,100	$	21,136	$	17,346	$	87,224
Net income per common share - basic	$	0.23	$	0.34	$	0.24	$	0.20	$	1.00
Net income per common share - diluted	$	0.22	$	0.33	$	0.24	$	0.20	$	0.98

2018	First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Year Ended
Revenue	$	141,425	$	146,791	$	154,246	$	155,828	$	598,290
Gross profit	$	43,920	$	45,769	$	52,409	$	54,582	$	196,680
Operating income/(loss)	$	11,922	$	(763)	$	24,231	$	27,848	$	63,238
Net income/(loss)	$	6,391	$	(3,367)	$	18,574	$	33,391	$	54,989
Net income/(loss) per common share - basic	$	0.08	$	(0.04)	$	0.22	$	0.40	$	0.66
Net income/(loss) per common share - diluted	$	0.07	$	(0.04)	$	0.22	$	0.38	$	0.64

(1)Third quarter 2019 results include the Company's sale of its investment in InstaMed, as described in Note 5(c).

(2)Second quarter 2018 results include the Company's entry into the Settlement Agreement for the payment of $20.0 million, as described in Note 14.